alexa Marina Prilutskaya | ProteoGenex, Inc
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Marina Prilutskaya

ProteoGenex, Inc
USA
Biography

Marina Prilutskaya is a co-founder of ProteoGenex, Inc. and has served as its Head of Operations since 2002. Marina Prilutskaya worked in the field of cancer research as a Laboratory Manager at BIS Laboratories and as a Director at IMPATH. Marina has broad expertise in Oncology, Molecular Diagnostics, and Immunology. Her research experience is more then 25 years. Marina Prilutskaya received a MSc degree in Molecular Biology from Moscow University and a PhD degree in Oncology from Cancer Research Center (Russian Academy of Science).

Research Interest

 Biotechnology

Publications

Quality Bio-Specimens for Novel Biomarker Discovery

Marina Prilutskaya, Julia Pustilnik, Olga Balukova, Natalia Dyakova, Dmitry Suchkov and Lena Fenik

Review Article: Transl Med 2012, S1-007

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords